Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intronic CRISPR Repair in a Preclinical Model of Noonan Syndrome–Associated Cardiomyopathy
Ulrich Hanses, Mandy Kleinsorge, Lennart Roos, et al.
Circulation (2020) Vol. 142, Iss. 11, pp. 1059-1076
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

The RASopathies: from pathogenetics to therapeutics
Katie E. Hebron, Edjay R. Hernandez, Marielle E. Yohe
Disease Models & Mechanisms (2022) Vol. 15, Iss. 2
Open Access | Times Cited: 117
Advances in CRISPR therapeutics
Michael Chavez, Xinyi Chen, Paul B. Finn, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 9-22
Open Access | Times Cited: 112
A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming
Davi M. Lyra‐Leite, Óscar Gutiérrez‐Gutiérrez, Meimei Wang, et al.
STAR Protocols (2022) Vol. 3, Iss. 3, pp. 101560-101560
Open Access | Times Cited: 75
Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research
Zhenhua Li, Jun Wang, Jingping Xu, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 32
Electrophysiological and calcium-handling development during long-term culture of human-induced pluripotent stem cell-derived cardiomyocytes
Fitzwilliam Seibertz, Henry Sutanto, Rebekka Dülk, et al.
Basic Research in Cardiology (2023) Vol. 118, Iss. 1
Open Access | Times Cited: 23
Accelerating cardiovascular research: recent advances in translational 2D and 3D heart models
Elisa Mohr, Thomas Thum, Christian Bär
European Journal of Heart Failure (2022) Vol. 24, Iss. 10, pp. 1778-1791
Open Access | Times Cited: 29
The Use of CRISPR-Cas9 Genetic Technology in Cardiovascular Disease: A Comprehensive Review of Current Progress and Future Prospective
Muhammad Asif, Wahab J Khan, Sadia Aslam, et al.
Cureus (2024)
Open Access | Times Cited: 7
Molecular and cellular evidence for the impact of a hypertrophic cardiomyopathy-associated RAF1 variant on the structure and function of contractile machinery in bioartificial cardiac tissues
Saeideh Nakhaei‐Rad, Fereshteh Haghighi, Farhad Bazgir, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 16
Preclinical evaluation of CRISPR-based therapies for Noonan syndrome caused by deep-intronic LZTR1 variants
Carolin Knauer, Henrike Haltern, Eric Schoger, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 1, pp. 102123-102123
Open Access | Times Cited: 5
Mutation-induced LZTR1 polymerization provokes cardiac pathology in recessive Noonan syndrome
Alexandra Viktoria Busley, Óscar Gutiérrez‐Gutiérrez, Elke Hammer, et al.
Cell Reports (2024) Vol. 43, Iss. 7, pp. 114448-114448
Open Access | Times Cited: 4
CRISPR-Cas9 in Cardiovascular Medicine: Unlocking New Potential for Treatment
Klaudia Bonowicz, Dominika Jerka, Klaudia Piekarska, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 131-131
Open Access
A Multidimensional Approach to Understanding Genetic Diversity, Risk Stratification, and Personalized Interventions in Pediatric Hypertrophic Cardiomyopathy
Mona Alromaihi, Faris Alrumaihi, Wanian M. Alwanian, et al.
Current Problems in Cardiology (2025), pp. 103040-103040
Closed Access
Cardiovascular aspects of Noonan syndrome and related disorders
Martin Zenker, Cordula M. Wolf
Medizinische Genetik (2025) Vol. 37, Iss. 2, pp. 113-124
Closed Access
Brugada Syndrome: Different Experimental Models and the Role of Human Cardiomyocytes From Induced Pluripotent Stem Cells
Yingrui Li, Siegfried Lang, İbrahim Akın, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 7
Open Access | Times Cited: 18
Human induced pluripotent stem cell (hiPSC)-derived cardiomyocyte modelling of cardiovascular diseases for natural compound discovery
Keyang Zhu, Xinhe Bao, Yingchao Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113970-113970
Open Access | Times Cited: 17
Novel insights in the pathomechanism of Brugada syndrome and fever‐related type 1 ECG changes in a preclinical study using human‐induced pluripotent stem cell‐derived cardiomyocytes
Yingrui Li, Hendrik Dinkel, Dalia Pakalniskyte, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 3
Open Access | Times Cited: 10
Cell cycle defects underlie childhood-onset cardiomyopathy associated with Noonan syndrome
Anna B. Meier, Sarala Raj Murthi, Hilansi Rawat, et al.
iScience (2021) Vol. 25, Iss. 1, pp. 103596-103596
Open Access | Times Cited: 23
The seventh international RASopathies symposium: Pathways to a cure—expanding knowledge, enhancing research, and therapeutic discovery
Maria I. Kontaridis, Amy E. Roberts, Lisa Schill, et al.
American Journal of Medical Genetics Part A (2022) Vol. 188, Iss. 6, pp. 1915-1927
Open Access | Times Cited: 14
Elastin stabilization prevents impaired biomechanics in human pulmonary arteries and pulmonary hypertension in rats with left heart disease
Mariya M. Kucherenko, Pengchao Sang, Juquan Yao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Cardiac Myoediting Attenuates Cardiac Abnormalities in Human and Mouse Models of Duchenne Muscular Dystrophy
Ayhan Atmanli, Andreas C. Chai, Miao Cui, et al.
Circulation Research (2021) Vol. 129, Iss. 6, pp. 602-616
Open Access | Times Cited: 19
Application of CRISPR-Cas9 gene editing for congenital heart disease
Heeyoung Seok, Rui Deng, Douglas B. Cowan, et al.
Clinical and Experimental Pediatrics (2021) Vol. 64, Iss. 6, pp. 269-279
Open Access | Times Cited: 16
A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells
Rujia Zhong, Theresa Schimanski, Feng Zhang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8313-8313
Open Access | Times Cited: 11
Functional Assays Reclassify Suspected Splice-Altering Variants of Uncertain Significance in Mendelian Channelopathies
Matthew J. O’Neill, Yuko Wada, Lynn Hall, et al.
Circulation Genomic and Precision Medicine (2022) Vol. 15, Iss. 6
Open Access | Times Cited: 11
Noonan syndrome patient-specific induced cardiomyocyte model carrying SOS1 gene variant c.1654A>G
Narasimman Gurusamy, Sheeja Rajasingh, Vinoth Sigamani, et al.
Experimental Cell Research (2021) Vol. 400, Iss. 1, pp. 112508-112508
Open Access | Times Cited: 13
Alteration of myocardial structure and function in RAF1-associated Noonan syndrome: Insights from cardiac disease modeling based on patient-derived iPSCs
Saeideh Nakhaei‐Rad, Farhad Bazgir, Julia Dahlmann, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top